+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Connected Drug Delivery Devices Market by Device Type, Drug Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Connected Drug Delivery Devices Market by Device Type, Drug Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Connected Drug Delivery Devices Market by Device Type, Drug Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014742
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Connected drug delivery devices are transforming how pharmaceutical firms, healthcare providers, and payers approach medication administration, patient engagement, and treatment outcomes. These devices, integrating advanced technologies, are setting new standards for therapy precision, compliance tracking, and healthcare operational efficiency.

Market Snapshot: Connected Drug Delivery Devices Market

The Connected Drug Delivery Devices Market grew from USD 966.22 million in 2024 to USD 1.11 billion in 2025. It is expected to continue growing at a CAGR of 14.68%, reaching USD 2.19 billion by 2030. Increasing integration of connectivity features with drug delivery platforms is driving adoption among providers seeking real-time data, robust compliance insights, and streamlined patient management. As digital health and smart technology continue to converge, stakeholders are expected to accelerate investments and partnerships throughout the value chain.

Scope & Segmentation

  • Device Types: Infusion pumps, inhalers, injection devices, nasal sprays, transdermal patches
  • Infusion Pump Varieties: Enteral, insulin, and PCA (patient-controlled analgesia) pumps
  • Inhaler Variants: Dry powder inhalers, metered dose inhalers, nebulizers
  • Injection Devices: Autoinjectors, pen injectors, safety syringes, standard syringes
  • Nasal Spray Mechanisms: Manual spray, nebulized spray
  • Transdermal Patch Formats: Matrix and reservoir patches
  • Drug Types: Biologics, biosimilars, small molecule therapies, vaccines
  • End Users: Ambulatory care centers, clinics, home care settings, and hospitals
  • Distribution Channels: Direct sales, hospital pharmacy, online pharmacy, retail pharmacy
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Medtronic plc, Becton Dickinson, Baxter International Inc., Roche Holding AG, Smiths Group plc, Insulet Corporation, Tandem Diabetes Care, Ypsomed Holding AG, Novo Nordisk A/S, Sanofi S.A.

Key Takeaways for Senior Decision-Makers

  • Connected drug delivery devices are enabling healthcare providers and payers to gain deeper insight into patient adherence and optimize personalized dosing.
  • Integration of advanced sensors and cloud platforms is providing actionable data streams, supporting both clinical decision-making and predictive analytics for risk mitigation.
  • Increasing focus on user-centric design is driving adoption across ambulatory care, hospitals, and in-home settings, as intuitive operation and minimal training needs become decisive factors.
  • Interoperability with electronic health records and digital health ecosystems is being recognized as essential, facilitating longitudinal patient monitoring and multi-stakeholder collaboration.
  • The evolution of reimbursement models and regulations requires manufacturers to adapt product strategies and compliance processes according to specific regional demands.
  • Emergence of new competitors and startup-driven innovation is influencing incumbents to develop integrated, scalable, and secure platforms that support future growth in digital therapeutics.

Tariff Impact and Supply Chain Adjustments

The implementation of new U.S. tariffs in 2025 presents cost and compliance challenges for manufacturers sourcing critical components globally. These include higher import duties on items like microelectromechanical systems and specialty polymers. In response, some firms are prioritizing local or near-shore assembly to address tariff-related cost pressures and bolster supply chain resilience. Contract renegotiations with suppliers and distributors, as well as greater reliance on regulatory and customs expertise, are strategies being employed to maintain efficiency and safeguard market access.

Methodology & Data Sources

This analysis leverages a combination of primary interviews with senior executives from manufacturer, provider, and payer organizations, and secondary research from industry publications, regulatory filings, patent records, and white papers. Data validation was conducted through panel review and methodological rigor, including benchmarking and coverage of recent tariff schedules and corporate strategy disclosures.

Why This Report Matters

  • Delivers comprehensive, actionable insights for strategic investment, partnership, and product innovation in the connected drug delivery devices market.
  • Equips senior leaders with an understanding of evolving compliance, technology integration, and regional market nuances that shape product adoption and growth potential.
  • Supports data-driven decision-making by presenting validated, segment-specific analysis grounded in broad industry expertise and real-world stakeholder perspectives.

Conclusion

Connected drug delivery devices are rapidly reshaping the future of healthcare delivery and medication management. Organizations that proactively embrace digital integration, localization, and patient-centric innovation will be well positioned to drive clinical and operational success in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Connected Drug Delivery Devices Market, by Device Type
8.1. Introduction
8.2. Infusion Pumps
8.2.1. Enteral Pumps
8.2.2. Insulin Pumps
8.2.3. PCA Pumps
8.3. Inhalers
8.3.1. Dry Powder Inhalers
8.3.2. Metered Dose Inhalers
8.3.3. Nebulizers
8.4. Injection Devices
8.4.1. Autoinjectors
8.4.2. Pen Injectors
8.4.3. Safety Syringes
8.4.4. Standard Syringes
8.5. Nasal Spray
8.5.1. Manual Spray
8.5.2. Nebulized Spray
8.6. Transdermal Patch
8.6.1. Matrix Patch
8.6.2. Reservoir Patch
9. Connected Drug Delivery Devices Market, by Drug Type
9.1. Introduction
9.2. Biologics
9.3. Biosimilars
9.4. Small Molecule
9.5. Vaccines
10. Connected Drug Delivery Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.3. Clinics
10.4. Home Care
10.5. Hospitals
11. Connected Drug Delivery Devices Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Hospital Pharmacy
11.4. Online Pharmacy
11.5. Retail Pharmacy
12. Americas Connected Drug Delivery Devices Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Connected Drug Delivery Devices Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Connected Drug Delivery Devices Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Medtronic plc
15.3.2. Becton, Dickinson and Company
15.3.3. Baxter International Inc.
15.3.4. Roche Holding AG
15.3.5. Smiths Group plc
15.3.6. Insulet Corporation
15.3.7. Tandem Diabetes Care, Inc.
15.3.8. Ypsomed Holding AG
15.3.9. Novo Nordisk a/S
15.3.10. Sanofi S.A.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CONNECTED DRUG DELIVERY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CONNECTED DRUG DELIVERY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CONNECTED DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CONNECTED DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CONNECTED DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ENTERAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PCA PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STANDARD SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MANUAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NEBULIZED SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY MATRIX PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RESERVOIR PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 68. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 69. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 70. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 71. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 72. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 125. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 126. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 132. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 134. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 135. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 136. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 149. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 150. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 151. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 152. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 153. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 154. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 155. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 158. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 159. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 160. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 161. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 162. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 163. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 195. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 196. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 197. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 198. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 199. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 200. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. DENMARK CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 212. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 213. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 214. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 215. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 216. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 217. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. QATAR CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 225. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 226. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 227. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. FINLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 249. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 250. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 251. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 252. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 253. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 254. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 257. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 258. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 259. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 261. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 262. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 263. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. TURKEY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 278. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 279. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 280. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 281. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. NORWAY CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 284. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 285. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 286. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 287. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 288. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 289. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 290. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. POLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL SPRAY, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL PATCH, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC CONNECTED D

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Connected Drug Delivery Devices market report include:
  • Medtronic plc
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Roche Holding AG
  • Smiths Group plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG
  • Novo Nordisk A/S
  • Sanofi S.A.

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.11 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.19 Billion
Compound Annual Growth Rate14.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Pulmonary Drug Delivery Devices Market by Device Type, Therapy, Drug Type, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Pulmonary Drug Delivery Devices Market by Device Type, Therapy, Drug Type, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region - Product Image

Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region

  • Report
  • 405 Pages
  • Global
From
Smart Drug Delivery Systems Market Report 2025 - Product Image

Smart Drug Delivery Systems Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Connected Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Connected Drug Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.